Healthcare Deals and Investments
Healthcare Deals and Investments
Healthcare Pulse
EMAIL DIGESTS
Daily
Every morning
Weekly
Tuesday recap
EMAIL DIGESTS
Daily
Every morning
Weekly
Tuesday recap
Abram Scientific, a Menlo Park‑based medical device firm specializing in coagulation diagnostics, announced the closing of an $11.75 million Series A round. The financing was led by Octapharma AG with participation from investors affiliated with the University of Colorado Anschutz. The capital will support product development and market expansion.
BrainCheck, a digital platform for cognitive assessment and care, announced a $13 million Series A financing round. The round was led by Next Coast Ventures with participation from S3 Ventures and UPMC Enterprises. The funding will support the company's growth and expansion...
Honest Health announced a $140 million fundraising round led by NewSpring Healthcare, with participation from K2 HealthVentures, Rubicon Founders, Oak HC/FT and other investors. The capital will be used to expand its value‑based care enablement platform across national health systems...
Natera announced the acquisition of Foresight Diagnostics during its Q4 2025 earnings call on Feb. 26, 2026. The deal adds Foresight's phased‑variant technology to Natera's Signatera platform, enabling detection below one fragment per 10 million normal copies. Financial terms were not...
Reframe Cancer, the UK's leading specialist cancer navigation provider, has acquired Alvie Health, a digital cancer prehabilitation business founded by NHS surgeon Krishna Moorthy. The acquisition makes Reframe Cancer the largest cancer support business in the UK and will enable...
Japanese drugmaker Asahi Kasei announced it will acquire German biotech Aicuris for €780 million, gaining its antiviral therapy pritelivir targeting HSV. The deal expands Asahi Kasei's anti‑infectives portfolio and supports its goal of reaching JPY 300 billion in pharma sales by 2030.
Uplift Hospice announced the acquisition of Georgia-based Autumn View Hospice for an undisclosed amount, expanding its daily census to over 650 patients across Arizona, Nevada, Texas and Georgia. The deal, facilitated by M&A advisory firm Agenda Health, will retain all...
GlaxoSmithKline (GSK) announced the acquisition of privately held 35Pharma, a developer of a pulmonary arterial hypertension drug. The cash deal is valued at just under $1 billion, expanding GSK’s pipeline in respiratory and immunology.
Dovida, a home‑care provider operating in six international markets, announced the acquisition of Omaha‑based A Place At Home, marking its entry into the United States. The financial terms were not disclosed, and the A Place At Home brand and leadership...
Quadria Capital, an Asian healthcare‑focused private equity firm, has completed the acquisition of Apex Healthcare, taking it private in a deal valued at $470 million. The transaction, backed by co‑investors 65 Equity Partners, the Employees Provident Fund and Silk Road Fund,...
South Korean medical AI firm Vuno announced a strategic investment of 10 billion won ($7 million) from the Compass Pathway NXVP New Technology Investment Fund No. 1. The funds will be issued as perpetual convertible bonds and used for operating capital to fuel...
Comanche County Memorial Hospital announced an agreement to acquire Southwestern Medical Center, forming the Memorial Health System of Southwest Oklahoma. The deal, reported in early 2026, adds a 199‑bed rural hospital to the 265‑bed system, expanding its regional footprint.
The Lockwood Group announced it has acquired Total Health, a leading provider of free oncology medical education. The deal expands Lockwood’s educational portfolio and strengthens its position in oncology communications and clinical insights. Financial terms were not disclosed.
Sunway Healthcare, a leading private healthcare provider in Malaysia, announced plans for an IPO that could raise over RM3 billion, the largest in the country in nearly a decade. AIA and Malaysia’s Employees Provident Fund are among more than 20...
Private equity firm Kinderhook Industries announced an agreement to acquire home‑health and hospice provider Enhabit Inc. in an all‑cash transaction valued at approximately $1.1 billion, taking the company private. The deal, expected to close in Q2 2026, will pay Enhabit shareholders $13.80...
Gilead Sciences announced it will acquire biotech Arcellx in a cash deal valued at up to $7.8 billion, paying $115 per share plus a contingent $5 per share based on future sales. The acquisition aims to strengthen Gilead's cancer drug pipeline,...
Coral Care, a platform delivering in‑home pediatric speech, occupational and physical therapy, announced a $13 million Series A round. The round was led by Haymaker Ventures with participation from FCA Ventures, Peterson Ventures and several other investors. The capital will fund national...
Australian health‑tech scale‑up Heidi announced the acquisition of UK AI healthcare platform Automedica, expanding its AI product suite and UK regulatory presence. The terms were undisclosed. The deal follows Heidi’s $125 million fundraising round last year.
RevSpring, backed by Frazier Healthcare Partners, announced the acquisition of TrustCommerce, a portfolio company of Waud Capital Partners, to build an end‑to‑end healthcare payment platform. The deal adds TrustCommerce’s enterprise gateway and EHR integrations to RevSpring’s patient engagement software, creating...
Voyageur Pharmaceuticals Ltd. announced a collaboration and milestone‑based funding agreement with Bayer, providing up to US$2.35 million to advance an iodine production project in Oklahoma. Funding will be released in three stages tied to feasibility‑study milestones, with Bayer receiving exclusivity to...
Candel Therapeutics announced a $100 million royalty financing agreement with RTW Investments to support the launch of its gene therapy Aglatimagene Besadenovec for localized prostate cancer. The deal grants RTW a capped, tiered royalty on U.S. net sales, contingent on...
BridgePoint Healthcare has sold its skilled nursing facility at 4601 Martin Luther King Jr. Ave. SW in Washington, D.C. to Hill Valley Healthcare for $79 million, according to deed records. Hill Valley financed the acquisition with a $53.7 million loan from Deutsche Bank,...
AlayaCare Inc., a Montreal‑based provider of home and community care software, secured a $50 million growth‑capital facility from CIBC Innovation Banking. The funding will fuel the company's expansion and support strategic mergers and acquisitions. The partnership builds on a relationship dating...
Denver-based Axis Medical, a distributor of spinal implant and orthobiologic technologies, received an undisclosed investment from Spur Ridge Capital. The funding will be used to accelerate growth through operational infrastructure, sales initiatives, and strategic expansion, including acquisitions, while the company...
W. L. Gore & Associates, the materials‑science company, has finalized its acquisition of Conformal Medical, the developer of the CLAAS AcuFORM left atrial appendage occlusion system. Financial terms were not disclosed. Conformal Medical becomes a wholly‑owned subsidiary of Gore, continuing...
Flinn announced a $20 million fundraising round to accelerate development of artificial intelligence tools for product lifecycle management in the medtech and pharmaceutical sectors. The capital will be used to build AI-driven solutions that streamline design, compliance, and market launch...
Direct-to-consumer virtual care company Hims & Hers announced it has signed an agreement to acquire international digital health platform Eucalyptus for up to $1.15 billion. The transaction includes $240 million cash at closing and the remainder in deferred and earn‑out payments, with...
Synchrony Medical announced a $5 million fundraising round to fund the commercialization of its LibAirty airway clearance system. The capital will be used to scale production, pursue regulatory approvals, and expand market reach. The round marks a significant step in...
Korsana, a biotech focused on Alzheimer’s disease, announced a $150 million Series A funding round to advance its next‑generation amyloid‑targeting antibody. The capital will fund clinical development and expansion of its pipeline. Investor identities were not disclosed.
Charles River Laboratories International Inc announced the closing of its acquisition of KF Cambodia, a long‑time non‑human primate supplier, to strengthen its Discovery and Safety Assessment (DSA) supply chain and reduce costs. The deal, finalized in early 2026, is expected...
Gilead Sciences announced a deal to acquire Genhouse for over $1.5 billion, aiming to strengthen its synthetic lethality oncology pipeline. The acquisition brings Genhouse’s portfolio of synthetic lethality drug candidates and technology into Gilead’s pipeline, underscoring its commitment to precision oncology.
Sensei Biotherapeutics announced the acquisition of Faeth Therapeutics in a stock-for-stock transaction, consolidating the two biotech firms. Concurrently, Sensei raised $200 million in a private placement to fund the development of PIKTOR, its multi-node PI3K/AKT/mTOR inhibitor. The acquisition price was...
Rainfall Health, an AI-driven compliance platform for hospitals, announced the closing of a $15 million Series A round led by Two Bear Capital, with participation from other investors. The funding will support the company’s expansion as it helps hospitals meet new CMS...
Prenetics Global Limited announced the sale of its 35% equity stake in Insighta to Tencent for $70 million in cash, as part of its strategic transformation to focus on its IM8 health brand. The deal, reported on February 18 2026, provides Prenetics with...
Eli Lilly announced it will pay $100 million to CSL Limited for the rights to the IL‑6‑blocking antibody clazakizumab, with CSL retaining rights for cardiovascular prevention in end‑stage kidney disease patients. The deal includes an upfront payment and potential milestone and...
Cencora announced a $3.5 billion merger with Covetrus, creating a leading animal health company. The transaction, guided by three advisory firms, combines Cencora's distribution capabilities with Covetrus's veterinary services platform. The deal is expected to close later this year.
Biotech firm Unnatural Products announced a $1.8 billion partnership with pharmaceutical giant Novartis to develop cardiovascular therapies. The agreement includes a corporate investment from Novartis, marking a significant funding boost for Unnatural Products.
Australian health‑tech platform HotDoc has been acquired by private‑equity firm Potentia, which led a bid for a majority stake. The deal, valued between $250 million and $300 million, also brings health‑tech investor Acclivis Group and long‑term backer Airtree into the ownership group....
Rome‑based digital health startup VoiceMed announced it has closed a €1 million seed round, receiving public funding from Invitalia and private investments from GCM Group, Padda Health and 28Digital. The funds will be used to accelerate clinical studies and market entry...
Natera announced the completion of its acquisition of Foresight Diagnostics, a company specializing in cancer diagnostics. The deal expands Natera's oncology testing portfolio. Financial terms were not disclosed.
Danaher announced it will acquire medical‑technology company Masimo for $9.9 billion, offering $180 per share, a 38.3% premium to Masimo's last closing price. The acquisition aims to strengthen Danaher's diagnostics portfolio.
Innovative Consulting Group (ICG), a portfolio company of SV Health Investors, announced the acquisition of Pivot Point Consulting, a healthcare consulting firm, with the combined entity operating under the Pivot Point brand. The transaction, backed by investors Health Enterprise Partners...
Medica Group announced it will acquire Axon Diagnostics, along with its sister company MITIS Health, to create the UK's largest clinical reporting network for the NHS and independent healthcare sector. The combined entity will serve over 2.5 million patients across...
Codoxo announced a $35 million Series C funding round led by CVS Health Ventures, with participation from Echo Health Ventures and existing investors. The capital will accelerate the rollout of its AI-driven payment integrity platform across U.S. healthcare payers, enhancing fraud detection...
Evaro, an NHS‑licensed digital health platform, raised $25 million in a Series A round led by AlbionVC with participation from Simplyhealth Ventures, Exceptional Ventures, Cornerstone VC and BBI. The funding will accelerate its healthcare‑as‑a‑service model across consumer brands, healthcare organisations and employers.
VB Spine announced it has signed a definitive agreement to acquire Augmedics' xvision Spine System, adding augmented reality navigation to its visualization portfolio. The transaction, pending regulatory approval, is expected to close in the coming weeks and follows VB Spine's...
London‑based AI‑driven medtech startup Klaris announced the closing of a $1 million pre‑seed round to fund its regulatory compliance platform. The round was led by Meridian Health Ventures with participation from Antler, Vento Ventures, Alecla7 and other angel investors. The capital...
Nul, a UK‑based healthtech startup focused on alcohol reduction, announced a $1 million seed funding round. The round was led by dmg ventures and BYVP, with participation from a group of angel investors, and will fund the company’s UK commercial launch...
Immunic announced an oversubscribed private placement of up to $400 million, led by BVF Partners and joined by Avidity Partners, OrbiMed, Trails Edge Capital Partners, TCGX and Vivo Capital. The funds will support Phase III ENSURE studies for its multiple sclerosis therapy...
Helia Care, a Scottsdale-based SaaS provider for healthcare supply chain and billing, announced a $3 million funding round. The round was backed by In Revenue Capital and Habanero Ventures and will be used to expand operations and development. The platform...
